Literature DB >> 17996282

The metabolic syndrome and the risk of arterial and venous thrombosis.

Massimo Franchini1, Giovanni Targher, Martina Montagnana, Giuseppe Lippi.   

Abstract

The metabolic syndrome is a cluster of cardiometabolic risk abnormalities related to atherosclerosis. It represents a public health problem as it affects nearly 20-30% of the general population in various countries. While the metabolic syndrome is a well recognized risk factor for cardiovascular diseases, there is little evidence about its association with venous thromboembolism. In this review, we will summarize the current knowledge on the relationship between the metabolic syndrome and arterial and venous thrombosis from a pathogenic and clinical point of view.

Entities:  

Mesh:

Year:  2007        PMID: 17996282     DOI: 10.1016/j.thromres.2007.09.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Adipokines are associated with lower extremity venous disease: the San Diego population study.

Authors:  M A Allison; M Cushman; P W Callas; J O Denenberg; N E Jensky; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 2.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

3.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

Review 4.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

5.  Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

Authors:  Weifei Zhu; Wei Li; Roy L Silverstein
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

6.  Vertebral artery thrombosis: a rare presentation of primary polycythaemia.

Authors:  H L Gul; S Y M Lau; D Chan-Lam; J-P Ng
Journal:  BMJ Case Rep       Date:  2014-05-26

7.  Obesity Paradox in Patients With Deep Venous Thrombosis.

Authors:  Ayman El-Menyar; Mohammad Asim; Hassan Al-Thani
Journal:  Clin Appl Thromb Hemost       Date:  2017-09-07       Impact factor: 2.389

8.  Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.

Authors:  Manopriya Thiruvagounder; Shaheen Khan; Dhastagir S Sheriff
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

9.  [35-year old patient with severe thromboembolism].

Authors:  J-G Kluge; I Körner; G Kluge; U Froster; D Pfeiffer
Journal:  Internist (Berl)       Date:  2010-12       Impact factor: 0.743

10.  The influence of metabolic syndrome on hemodialysis access patency.

Authors:  Clinton D Protack; Akhilesh Jain; Penny Vasilas; Alan Dardik
Journal:  J Vasc Surg       Date:  2012-09-05       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.